Consumer Goods Companies Announce Divestitures, Dividends, Appointments and Financial Results - Research Report on Estee Lauder, Nu Skin, Unilever, Avon, and Elizabeth Arden

NEW YORK, August 20, 2013 /PRNewswire/ --

Today, Investors' Reports announced new research reports highlighting Estee Lauder Companies Inc. (NYSE: EL), Nu Skin Enterprises Inc. (NYSE: NUS), Unilever NV (NYSE: UN), Avon Products Inc. (NYSE: AVP), and Elizabeth Arden, Inc. (NASDAQ: RDEN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Estee Lauder Companies Inc. Research Report

On August 15, 2013, Estee Lauder Companies Inc. (Estee Lauder) reported its Q4 FY 2013 and full-year FY 2013 financial results (period ended June 30, 2013). For the quarter, the Company reported net sales of $2.4 billion, up 6.9% YoY. Diluted EPS grew to $0.24 during the quarter from $0.13 in Q4 FY 2012. For full-year FY 2013, net sales increased 4.8% YoY to $10.2 billion; and diluted EPS grew to $2.58, compared with $2.16 in FY 2012. Commenting on the results, Fabrizio Freda, President and CEO, said, "We concluded another outstanding fiscal year with a strong fourth quarter that saw high-single-digit sales gains and exceptional double-digit earnings per share growth. Fiscal 2013 marked another record year in which our Company achieved a number of historic milestones: $10 billion in net sales, 15.2% operating margin and $1 billion in net earnings." The Full Research Report on Estee Lauder Companies Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-15/EL]

Nu Skin Enterprises Inc. Research Report

On August 1, 2013, Nu Skin Enterprises Inc. (Nu Skin) and its Board of Directors approved a quarterly dividend of $0.30 per share. The Company informed that the dividend will be payable on September 11, 2013 to stockholders of record on August 23, 2013. The Full Research Report on Nu Skin Enterprises Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-15/NUS]

Unilever NV Research Report

On August 12, 2013, Unilever NV (Unilever) announced that it has agreed to divest its Wish-Bone and Western dressings brands to Pinnacle Foods Inc. for approximately $580 million, subject to regulatory approval. Kees Kruythoff, President of Unilever North America, said, "We believe that the potential of both the Wish-Bone and Western brands can now be more fully realised with Pinnacle Foods. As we continue to shape our portfolio to deliver sustainable growth for Unilever, this change will give us the focus to drive growth behind our core foods portfolio." The Company expects the transaction to close at the latter part of Q3 2013 or early Q4 2013. The Full Research Report on Unilever NV - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-15/UN]

Avon Products Inc. Research Report

On August 12, 2013, Avon Products Inc. (Avon) announced that Nancy Killefer has been elected as a member on the Company's board, effective September 1, 2013. "We are so pleased to welcome Nancy to Avon's Board. Her proven leadership in strategy development and execution, brand-building, and organizational efficiencies across sectors will contribute greatly as Avon progresses through its turnaround," said Doug Conant, Chairman of the Board of Directors of Avon Products, Inc. The Company informed that Ms. Killefer has 32 years of experience at McKinsey and has served as head of the firm's People Committee, leading the firm's recruiting and chairing the firm's personnel committees. The Full Research Report on Avon Products Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-15/AVP]

Elizabeth Arden, Inc. Research Report

On August 8, 2013, Elizabeth Arden, Inc. (Elizabeth Arden) reported its Q4 FY 2013 and full-year FY 2013 financial results (period ended June 30, 2013). For the quarter, net sales totaled $267.6 million, up 0.8% YoY, while adjusted net income per diluted share was $0.10 compared to $0.28 in Q4 FY 2012. For full-year FY 2013, the Company reported net sales growth of 8.6% YoY to $1.3 billion. Adjusted net income per diluted share was $2.14 compared to $2.07 in FY 2012. E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth Arden, Inc. said, "Our priorities remain to accelerate the global growth of the Elizabeth Arden brand, expand sales of our fragrance portfolio, particularly internationally, and continue to drive operational efficiencies." The Company anticipates sales growth for FY 2014 in the range of 3.0% to 5.0% and adjusted earnings per diluted share to be in the range of $0.13 to $0.18. The Full Research Report on  Elizabeth Arden, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-15/RDEN]

EDITOR NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
5. For any urgent concerns or inquiries, please contact us at [email protected].
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

www.InvestorsReports.com

SOURCE Investors' Reports